- Home
- Publications
- Publication Search
- Publication Details
Title
Androgen Receptor Signaling in Bladder Cancer
Authors
Keywords
-
Journal
Cancers
Volume 9, Issue 12, Pages 20
Publisher
MDPI AG
Online
2017-02-23
DOI
10.3390/cancers9020020
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinicopathological Features and Prognostic Value of Incidental Prostatic Adenocarcinoma in Radical Cystoprostatectomy Specimens: A Systematic Review and Meta-Analysis of 13,140 Patients
- (2017) Omar Fahmy et al. JOURNAL OF UROLOGY
- Suppressed Recurrent Bladder Cancer after Androgen Suppression with Androgen Deprivation Therapy or 5α-Reductase Inhibitor
- (2017) Masaki Shiota et al. JOURNAL OF UROLOGY
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Expression of steroid hormone receptors and its prognostic significance in urothelial carcinoma of the upper urinary tract
- (2016) Eiji Kashiwagi et al. CANCER BIOLOGY & THERAPY
- Male hormones and menʼs quality of life
- (2016) Mohit Khera CURRENT OPINION IN UROLOGY
- Finasteride Reduces Risk of Bladder Cancer in a Large Prospective Screening Study
- (2016) Edwin E. Morales et al. EUROPEAN UROLOGY
- Enzalutamide inhibits proliferation of gemcitabine-resistant bladder cancer cells with increased androgen receptor expression
- (2016) Koji Kameyama et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Bladder Cancer Mortality in the United States: A Geographic and Temporal Analysis of Socioeconomic and Environmental Factors
- (2016) Norm D. Smith et al. JOURNAL OF UROLOGY
- Infiltrating T Cells Promote Bladder Cancer Progression via Increasing IL1->Androgen Receptor->HIF1 ->VEGFa Signals
- (2016) L. Tao et al. MOLECULAR CANCER THERAPEUTICS
- Conditional Expression of the Androgen Receptor Increases Susceptibility of Bladder Cancer in Mice
- (2016) Daniel T. Johnson et al. PLoS One
- Androgen receptor variant-driven prostate cancer: clinical implications and therapeutic targeting
- (2016) E S Antonarakis et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Enzalutamide inhibits androgen receptor–positive bladder cancer cell growth
- (2016) Takashi Kawahara et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Androgen receptor activity modulates responses to cisplatin treatment in bladder cancer
- (2016) Eiji Kashiwagi et al. Oncotarget
- Expression of androgen receptor in non-muscle-invasive bladder cancer predicts the preventive effect of androgen deprivation therapy on tumor recurrence
- (2016) Koji Izumi et al. Oncotarget
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Emerging therapeutic targets in bladder cancer
- (2015) Benedito A. Carneiro et al. CANCER TREATMENT REVIEWS
- Androgen receptor in human endothelial cells
- (2015) V. Torres-Estay et al. JOURNAL OF ENDOCRINOLOGY
- Compound A Inhibits Bladder Cancer Growth Predominantly via Glucocorticoid Receptor Transrepression
- (2015) Yichun Zheng et al. MOLECULAR ENDOCRINOLOGY
- ELK1 is up-regulated by androgen in bladder cancer cells and promotes tumor progression
- (2015) Takashi Kawahara et al. Oncotarget
- Secondary bladder cancer after anticancer therapy for prostate cancer: reduced comorbidity after androgen-deprivation therapy
- (2015) Masaki Shiota et al. Oncotarget
- The inverse relationship between bladder and liver in 4-aminobiphenyl-induced DNA damage
- (2015) Arup Bhattacharya et al. Oncotarget
- Tumor microenvironment B cells increase bladder cancer metastasis via modulation of the IL-8/androgen receptor (AR)/MMPs signals
- (2015) Zhenyu Ou et al. Oncotarget
- Infiltrating neutrophils increase bladder cancer cell invasion via modulation of androgen receptor (AR)/MMP13 signals
- (2015) ChangYi Lin et al. Oncotarget
- Androgen deprivation therapy prevents bladder cancer recurrence
- (2015) Koji Izumi et al. Oncotarget
- Loss of GATA3 in bladder cancer promotes cell migration and invasion
- (2014) Yi Li et al. CANCER BIOLOGY & THERAPY
- Activated androgen receptor promotes bladder cancer metastasis via Slug mediated epithelial-mesenchymal transition
- (2014) Yifeng Jing et al. CANCER LETTERS
- Androgen receptor immunohistochemistry in genitourinary neoplasms
- (2014) Elizabeth M. Williams et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- Prognostic Value of Sex-Hormone Receptor Expression in Non-Muscle-Invasive Bladder Cancer
- (2014) Jong Kil Nam et al. YONSEI MEDICAL JOURNAL
- Decreased Tumorigenesis and Mortality from Bladder Cancer in Mice Lacking Urothelial Androgen Receptor
- (2013) Jong-Wei Hsu et al. AMERICAN JOURNAL OF PATHOLOGY
- Androgen receptor inducing bladder cancer progression by promoting an epithelial-mesenchymal transition
- (2013) W. Jitao et al. ANDROLOGIA
- Constitutive -Catenin Activation Induces Male-Specific Tumorigenesis in the Bladder Urothelium
- (2013) C. Lin et al. CANCER RESEARCH
- Androgen activates β-catenin signaling in bladder cancer cells
- (2013) Yi Li et al. ENDOCRINE-RELATED CANCER
- Somatic Mutation of the Androgen Receptor Gene Is Not Associated with Transitional Cell Carcinoma: A “Negative” Study by Whole-exome Sequencing Analysis
- (2013) Song Wu et al. EUROPEAN UROLOGY
- Epidermal growth factor enhances androgen receptor-mediated bladder cancer progression and invasion via potentiation of AR transactivation
- (2013) TENG-FU HSIEH et al. ONCOLOGY REPORTS
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- Gender-specific differences in muscle-invasive bladder cancer: the concept of sex steroid sensitivity
- (2013) Georgios Gakis et al. WORLD JOURNAL OF UROLOGY
- On the Origins of the Androgen Receptor Low Molecular Weight Species
- (2013) Maria Mudryj et al. Hormones & Cancer
- Expression of androgen and oestrogen receptors and its prognostic significance in urothelial neoplasm of the urinary bladder
- (2012) Hiroshi Miyamoto et al. BJU INTERNATIONAL
- GATA binding protein 3 is down-regulated in bladder cancer yet strong expression is an independent predictor of poor prognosis in invasive tumor
- (2012) Hiroshi Miyamoto et al. HUMAN PATHOLOGY
- Epidermal growth factor induces bladder cancer cell proliferation through activation of the androgen receptor
- (2012) KOJI IZUMI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Androgen Receptor Signaling Regulates Cell Growth and Vulnerability to Doxorubicin in Bladder Cancer
- (2012) Masaki Shiota et al. JOURNAL OF UROLOGY
- Expression of UDP-glucuronosyltransferase 1A in bladder cancer: Association with prognosis and regulation by estrogen
- (2012) Koji Izumi et al. MOLECULAR CARCINOGENESIS
- CD24 expression is important in male urothelial tumorigenesis and metastasis in mice and is androgen regulated
- (2012) J. B. Overdevest et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Androgen Deprivation Induces Bladder Histological Abnormalities and Dysfunction via TGF-β in Orchiectomized Mature Rats
- (2012) Yong Zhang et al. TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- Dihydrotestosterone upregulates the expression of epidermal growth factor receptor and ERBB2 in androgen receptor-positive bladder cancer cells
- (2011) Y. Zheng et al. ENDOCRINE-RELATED CANCER
- Androgen receptor signals regulate UDP-glucuronosyltransferases in the urinary bladder: A potential mechanism of androgen-induced bladder carcinogenesis
- (2011) Koji Izumi et al. MOLECULAR CARCINOGENESIS
- Role of androgen receptor and associated lysine-demethylase coregulators, LSD1 and JMJD2A, in localized and advanced human bladder cancer
- (2011) Eric C. Kauffman et al. MOLECULAR CARCINOGENESIS
- Minireview: Alternative Activation Pathways for the Androgen Receptor in Prostate Cancer
- (2011) Kristin R. Lamont et al. MOLECULAR ENDOCRINOLOGY
- Loss of androgen receptor expression is not associated with pathological stage, grade, gender or outcome in bladder cancer: a large multi-institutional study
- (2010) Carmen Mir et al. BJU INTERNATIONAL
- Androgen Receptor Is a Potential Therapeutic Target for Bladder Cancer
- (2010) Ji-Tao Wu et al. UROLOGY
- Sex-specific hormone receptors in urothelial carcinomas of the human urinary bladder: A comparative analysis of clinicopathological features and survival outcomes according to receptor expression
- (2009) Can Tuygun et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Economic aspects of bladder cancer: what are the benefits and costs?
- (2009) K. D. Sievert et al. WORLD JOURNAL OF UROLOGY
- Progression of prostate cancer: Multiple pathways to androgen independence
- (2008) Hong-Lin Devlin et al. CANCER LETTERS
- Expression and significance of androgen receptor coactivators in urothelial carcinoma of the bladder
- (2008) Stephen A Boorjian et al. ENDOCRINE-RELATED CANCER
- Androgen deprivation therapy for prostate cancer
- (2008) Eric A Singer et al. EXPERT OPINION ON PHARMACOTHERAPY
- The effect of smoking on the male excess of bladder cancer: A meta-analysis and geographical analyses
- (2008) Marjolein Hemelt et al. INTERNATIONAL JOURNAL OF CANCER
- Somatic mutations of adenomatous polyposis coli gene and nuclear b-catenin accumulation have prognostic significance in invasive urothelial carcinomas: Evidence for Wnt pathway implication
- (2008) Efstathios Kastritis et al. INTERNATIONAL JOURNAL OF CANCER
- Temporal-Spatial Protein Expression in Bladder Tissue Derived From Embryonic Stem Cells
- (2008) John C. Thomas et al. JOURNAL OF UROLOGY
- Lower urinary-tract symptoms and testosterone in elderly men
- (2008) Aksam A. Yassin et al. WORLD JOURNAL OF UROLOGY
- Androgenic dependence of exophytic tumor growth in a transgenic mouse model of bladder cancer: a role for thrombospondin-1
- (2008) Aimee M Johnson et al. BMC Urology
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started